PEAK6 Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-257,400
Closed -$25.6M 4414
2019
Q3
$25.6M Sell
257,400
-34,300
-12% -$3.26M 0.16% 108
2019
Q2
$27M Sell
291,700
-134,300
-32% -$12.8M 0.18% 97
2019
Q1
$40.2M Buy
426,000
+235,100
+123% +$20.6M 0.24% 71
2018
Q4
$12.2M Sell
190,900
-79,900
-30% -$5.9M 0.08% 277
2018
Q3
$24.2M Buy
+270,800
New +$23.9M 0.11% 185

Other funds holding CELG

PEAK6 Investments's CELG Position: Q4 2019 in Review

PEAK6 Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 45,327 shares — an estimated $4.5M sold.

PEAK6 Investments first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $9.41M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • PEAK6 Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • PEAK6 Investments sold 45,327 Celgene Corp shares in Q4 2019, an estimated $4.5M.
  • PEAK6 Investments first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
  • PEAK6 Investments's Celgene Corp position peaked at $9.41M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on PEAK6 Investments's 13F filing for Q4 2019, filed 13 Feb 2020.